miR-29b acts as a tumor suppressor and is generally inhibited in the majority of human cancers, whereas MMP-2 is involved in breaking down the extracellular matrix, and inhibiting the expression of the HPV16E7 gene which leads to increased levels of vimentin and fibronectin involved in cancer development [91,94]. Here, MMP2 is linked to cancer.